GlassScriptPhysician profile
Gibson Ann Hernandez
NPI 1811408644
$2,271.12
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $852 · 2022: $966 · 2023: $215 · 2024: $238.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $453.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $452.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $714.99 | 2021-2023 | |
| Lilly USA, LLC | $295.46 | 2021-2024 | Mounjaro |
| Abbvie INC. | $243.23 | 2021-2023 | |
| Abbott Laboratories | $167.38 | 2021-2024 | Freestyle Libre 3 |
| Dexcom, INC. | $103.21 | 2022-2023 | Dexcom G6 Transmitter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $101.92 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $73.94 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $66.22 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $59.79 | 2021-2022 | |
| Pfizer INC. | $59.59 | 2021 | |
| Glaxosmithkline, LLC. | $56.17 | 2021-2022 | |
| Amarin Pharma, INC. | $51.32 | 2021 | |
| Biogen, INC. | $46.34 | 2021 | |
| Novartis Pharmaceuticals Corporation | $46.02 | 2022 | |
| Exact Sciences Corporation | $37.70 | 2023-2024 | Cologuard Collection Kit |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vivus LLC | $31.00 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $29.91 | 2022 | |
| Sanofi-Aventis U.S. LLC | $27.81 | 2022 | |
| Amgen INC. | $23.75 | 2022 | |
| Linus Health, INC. | $19.00 | 2023 | |
| Avanir Pharmaceuticals, INC. | $16.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gibson Hernandez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.